The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. (Q34644369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

ChEBI release 2020-05-28

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Alan L Pehrson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Nasser Haddjeri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Adeline Etiévant

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Bjarke Ebert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Connie Sánchez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

22 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

The International Journal of Neuropsychopharmacology

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1115-1127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

5-HT3 receptor antagonists reverse helpless behaviour in rats

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Effect of chronic activation of 5-HT3 receptors on 5-HT3, 5-HT(1A) and 5-HT(2A) receptors functional activity and expression of key genes of the brain serotonin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Electrophysiological diversity of the dorsal raphe cells across the sleep-wake cycle of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

5HT(3) antagonism abolishes the emotion potentiated startle effect in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Partial dopamine agonists in the treatment of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

A dose-finding study of duloxetine based on serotonin transporter occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Electrolytic lesions of the medial prefrontal cortex do not interfere with long-term memory of extinction of conditioned fear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Serotonin 5-HT(3) receptors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Serotonin and prefrontal cortex function: neurons, networks, and circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Role of 5-HT3 Receptors in the Antidepressant Response

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

The pharmacology of putative early-onset antidepressant strategies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Beyond the monoamine hypothesis: mechanisms, molecules and methods

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001058

7 January 2021

10.1017/S1461145712001058

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089374%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference